At Amniotic Stem Cells, we specialize in advanced wound technology products. We offer a range of allograft products that are suitable for surgical, diabetic, arterial, and venous wounds, providing relief to your patients.

Our grafts originate from the inner layer of a human placenta and are ethically obtained through donations from planned cesarean sections. These grafts undergo rigorous testing to ensure they are free from communicable diseases.

RISKS: None. There have been no reported adverse effects, and the documented success rate in achieving full wound closure is up to 95%, with results achieved in less than 8 weeks.

CHARACTERISTICS: Our patches are lightweight, thin, and comfortable. It naturally adheres to the wound without the need for stitches or pain. It’s packed with healing and growth factors and is flexible, allowing it to form to any wound of multiple sizes.

FDA-regulated, ATTB-compliant, EB sterilized, 3-year shelf life (ambient temperature). Medicare Plan-B, if qualified.